Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots Using Lanthanide Immunofluorescent Assay "17α-OH-PROGESTERONE-NEOSCREEN" According to TU 9398-038-49941990-2009

Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots Using Lanthanide Immunofluorescent Assay "17α-OH-PROGESTERONE-NEOSCREEN" According to TU 9398-038-49941990-2009

The reagent kit is designed for the quantitative determination of 17α-hydroxyprogesterone in dried blood spot samples using the lanthanide immunofluorescent assay method. This diagnostic tool ensures high accuracy and reliability for neonatal and clinical screening applications.

Product Details:

• Product Name: "17α-OH-PROGESTERONE-NEOSCREEN"
• Application: Quantitative measurement of 17α-hydroxyprogesterone in dried blood samples
• Method: Lanthanide immunofluorescent analysis
• Technical Specifications: TU 9398-038-49941990-2009

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots Using Lanthanide Immunofluorescent Assay "17α-OH-PROGESTERONE-NEOSCREEN" According to TU 9398-038-49941990-2009, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.